top of page

Licensing agreement for a novel SARS Cov-2 virus neutralization antibody test was signed

We are very happy to inform you that i&i Prague has participated on a development of novel in vitro diagnostics test measuring virus neutralization antibodies against SARS Cov-2 in human blood. The project was successfully completed and the Institute of Organic Chemistry and Biochemistry (IOCB) and the Institute of Biotechnology (IBT) have signed an exclusive license agreement with the company Immunotech, the Prague based subsidiary of Beckman Coulter.

Read more information on IOCB webpage.

12 mouse monoclonal antibody clones against different domains of SARS Cov-2 Spike protein were generated in this project and are available for research or other use.

For more information about the new test and the available antibody clones, contact: Dr. Jiří Moos

bottom of page